Wayne State University
Medical Student Research Symposium

School of Medicine

March 2020

Pannus sign on ultrasound and magnetic resonance imaging
predicts placenta percreta and is associated with high estimated
blood loss
Karin Fox
Baylor College of Medicine, karin.fox@bcm.edu

Tushar Shetty
tshetty@med.wayne.edu

Follow this and additional works at: https://digitalcommons.wayne.edu/som_srs
Part of the Obstetrics and Gynecology Commons

Recommended Citation
Fox, Karin and Shetty, Tushar, "Pannus sign on ultrasound and magnetic resonance imaging predicts
placenta percreta and is associated with high estimated blood loss" (2020). Medical Student Research
Symposium. 8.
https://digitalcommons.wayne.edu/som_srs/8

This Research Abstract is brought to you for free and open access by the School of Medicine at
DigitalCommons@WayneState. It has been accepted for inclusion in Medical Student Research Symposium by an
authorized administrator of DigitalCommons@WayneState.

Authors: Fox KA, Castillo J, Shetty T, Subramanian D, Shamshirsaz AA, Rac M,
Cassady CI, Belfort MA
Pannus sign on ultrasound and magnetic resonance imaging predicts placenta
percreta and is associated with high estimated blood loss
Objective: Antenatal identification of the placenta accreta spectrum (PAS) has
been estimated to be approximately 50% in multicenter and population based
data, with sensitivity and specificity far lower than that reported from referral
center cohorts. Easily obtained, objective markers are key to improving antenatal
detection. We noted that in many PAS cases, the placenta bulges over the
cervical os, like an abdominal pannus over a belt. The depth of the “pannus” can
be measured on ultrasound (US) and magnetic resonance imaging (MRI). We
predicted that a positive sign can differentiate between percreta and
increta/accreta.
Study Design: Retrospective chart review of a database of patients with PAS
from Jan 2012-Jun 2019. Demographic and clinical data were abstracted.” for US
and MRI images were reviewed and measurements recorded by trained
researchers blinded to clinical data. The pannus sign was measured in sagittal
plane (Figure). The pannus measurement (PM) drawn parallel to the cervical
canal from the most caudal placental point to the IOL is the “pannus,” when
positive, measured in mm. Negative (-) values indicate placenta cephalad to and
positive (+) values were at or more caudal to the IOL. Sensitivity, specificity, PPV
and NPV were calculated using the Chi-squared test.
Results: Of 164 women who had pathology proven PAS, 131 had adequate
images, of which 120 had US, 54 had MRI and 43 had both. One with fundal
PAS was excluded. 90 women had a (+) value, and 30 a (–) value on US. MR
agreed with US in all but 4 cases (91%, mean difference 7.4mm.) The sensitivity
and specificity were: 82.7% [95% CI, 72.5-89.6%] & 37.7% [95% CI, 25.1-77.5%]
with a PPV of 68.9 and NPV of 57%. The PM was associated with
Conclusion: A positive pannus sign is senstitive for percreta, but not specific;
cases of parametrial or high invasion will not be detected using this sign. There is
excellent agreement between US and MRI measurements and it was easily
obtained when the cervical canal could be seen. Studies of reproducibility and
use with other markers of PAS are needed.

Figure 1. Measurement of the pannus sign. Panel A, ultrasound; Panel B, MRI.
The outline of the placenta is shown in fine white dash. Note the similarity in
shape to the abdominal pannus on MRI. The cervical canal is identified (heavy
dashed line). A line is drawn perpendicular to the cervical canal to identify the
internal os line (IOL, thin solid). A line parallel to the cervical canal is then
measured in mm from the lowermost edge of placenta to the IOL (heavy solid).
The pannus measurement is positive, as the placental edge is caudal to the IOL.

